Thank you for your inquiry.
We will contact you within a few business days.
(Business Unit Performance Materials, Sales Support Team)
Gedung AIA Central, Level 39, Jl. Jend. Sudirman Kav. 48A, Jakarta Selatan, Indonesia
+62 21 2988 8557
Success! Your inquiry has been submitted to our Sales team.
Something went wrong! Please try after some time.
We have found 60 items.
Requestor's contact details | |
Full name | |
Company | |
Position | |
Telephone number | |
Work email address | |
Shipping address |
Thank you. Your request has been sent.
ACEMETACINE is a non-steroidal anti-inflammatory drug (NSAID) used for the treatment of osteoarthritis, rheumatoid arthritis, lower back pain, and relieving post-operative pain.
Products still subject to third-party patent protection might be available solely for R&D purposes.
BEXAROTENE MICRONIZED is an antineoplastic (anti-cancer) agent used for the treatment of cutaneous T cell lymphoma (CTCL). It is a third-generation retinoid.
Products still subject to third-party patent protection might be available solely for R&D purposes.
APIXABAN is an anticoagulant medication used to treat and prevent blood clots and to prevent stroke in people with nonvalvular atrial fibrillation through directly inhibiting factor Xa.
Products still subject to third-party patent protection might be available solely for R&D purposes.
TERBINAFINE HCL is an antifungal medication used to treat pityriasis versicolor, fungal nail infections, and ringworm, including jock itch and athlete's foot.
Products still subject to third-party patent protection might be available solely for R&D purposes.
RACECADOTRIL is an antidiarrheal medication which acts as a peripheral enkephalinase inhibitor. RACECADOTRIL has an antisecretory effect - it reduces the secretion of water and electrolytes into the intestine.
Products still subject to third-party patent protection might be available solely for R&D purposes.
As a novel potassium-competitive acid blocker, VONOZOPRAN FUMARATE may provide reversible acid suppression by preventing K+ from binding to gastric H+/K+-ATPase. It has been clinically used for the short-term treatment of gastroesophageal reflux disease (GERD), peptic ulcer disease and Helicobacter pylori (H. pylori) infection.
Products still subject to third-party patent protection might be available solely for R&D purposes.